Single-dose parvo treatment gets USDA approvalMay 3, 2023Elanco’s Canine Parvovirus Monoclonal Antibody treatment may provide a less intensive solution by targeting the virus with single-dose efficacy in dogs.
SPONSORED CONTENTA Modern Approach to Parasite PreventionWith evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection. + Learn More
Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
Preventative for deadly puppy disease may be imminentSeptember 18, 2020An efficacy study of a monoclonal antibody targeting canine parvovirus has shown complete efficacy in its prevention, its maker says.
Canine parvovirus treatment may be in the worksAugust 19, 2019Veterinarians may soon have access to an antibody effective in the treatment of canine parvovirus (CPV).
